Previous 10 | Next 10 |
Gainers: InnSuites Hospitality Trust (IHT) +95%.Regional Health Properties (RHE) +30%.Cooper-Standard (CPS) +25%.MoneyGram International (MGI) +23%.Epizyme (EPZM) +21%.The L.S. Starrett (SCX) +21%.Clene (CLNN) +20%.Yield10 Bioscience (YTEN) +20%.Phio Pharmaceuticals (PHIO) +19%.Core...
WOBURN, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its first quarter 2021 financial results and provide a corporate update on Tuesday, May 11, 2021. Management will ho...
Gainers: Gulf Island Fabrication (GIFI) +15%, Nine Energy Service (NINE) +9%, Olympic Steel (ZEUS) +8%, Universal Stainless & Alloy Products (USAP) +7%, Yield10 Bioscience (YTEN) +7%.Losers: Recon Technology (RCON) -29%, Independence Contract Drilli...
The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with this event. For further details see: Yield10 Bioscience (YTEN) Presents At Benzinga Biotech Small Cap Virtual Conference - Slideshow
WOBURN, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that it will be featured as a presenting company at the Benzinga Biotech Small Cap Conference to be held on March 24-25, 2021 in a virtual f...
The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Yield10 Bioscience, Inc. 2020 Q4 - Results - Earnings Call Presentation
Yield10 Bioscience, Inc. (YTEN) Q4 2020 Earnings Conference Call March 16, 2021 04:30 PM ET Company Participants Lynne Brum – Vice President-Planning and Corporate Communications Oliver Peoples – President and Chief Executive Officer Kristi Snell – Vice President of Resea...
Yield10 Bioscience (YTEN) shares rise more than 10% during post market trading after the company posted a 43% jump in fourth quarter revenue.The company posted Q4 revenue of $0.2M, an increase of 43% from last year, but missed analysts' average estimate by $0.05M.Yield10 said that i...
Yield10 Bioscience (YTEN): Q4 GAAP EPS of -$0.79 misses by $0.09.Revenue of $0.2M (+42.9% Y/Y) misses by $0.05M.Shares +11%.Press Release For further details see: Yield10 Bioscience EPS misses by $0.09, misses on revenue
WOBURN, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended December 31, 2020. "In 2020 we continued to execute our business plan, and successf...
News, Short Squeeze, Breakout and More Instantly...
Yield10 Bioscience Inc. Company Name:
YTEN Stock Symbol:
NASDAQ Market:
- Nufarm to pay up to USD $5 million in consideration for the license -The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“...
WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that U.K.-based Rothamsted Research Limited (“Rothamsted”)...
- EPA approved an amendment to the label of INTERLINE herbicide to include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield1...